Sol-Gel Technologies Ltd. (SLGL): Price and Financial Metrics

Sol-Gel Technologies Ltd. (SLGL): $0.44

0.01 (+2.32%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add SLGL to Watchlist
Sign Up

SLGL Price/Volume Stats

Current price $0.44 52-week high $1.58
Prev. close $0.43 52-week low $0.33
Day low $0.44 Volume 51,900
Day high $0.47 Avg. volume 139,633
50-day MA $0.62 Dividend yield N/A
200-day MA $0.78 Market Cap 12.29M

SLGL Stock Price Chart Interactive Chart >


Sol-Gel Technologies Ltd. (SLGL) Company Bio


Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company’s lead product candidates include VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea; and TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris. It is also involved in the development of generic dermatological candidates; and formulation and pre-clinical development of early stage product candidates for acne and rosacea, and other dermatological indications. The company was founded in 1997 and is based in Ness Ziona, Israel


SLGL Latest News Stream


Event/Time News Detail
Loading, please wait...

SLGL Latest Social Stream


Loading social stream, please wait...

View Full SLGL Social Stream

SLGL Price Returns

1-mo -34.33%
3-mo -31.89%
6-mo -45.00%
1-year -68.43%
3-year -94.43%
5-year -94.44%
YTD -60.18%
2023 -75.77%
2022 -38.38%
2021 -24.41%
2020 -42.92%
2019 184.88%

Continue Researching SLGL

Want to see what other sources are saying about Sol-Gel Technologies Ltd's financials and stock price? Try the links below:

Sol-Gel Technologies Ltd (SLGL) Stock Price | Nasdaq
Sol-Gel Technologies Ltd (SLGL) Stock Quote, History and News - Yahoo Finance
Sol-Gel Technologies Ltd (SLGL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!